CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

Quinapril hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 11 USDMF, 4 CEP/COS, 5 EU WC, 5 NDC API, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

205 FDF Dossiers, 77 FDA Orange Book, 90 Europe, 4 Canada, 8 Australia, 26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 9 SPI Pharma, 2 Seqens, 10 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 5 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 15 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 40 Direct Compression, 33 Controlled & Modified Release, 28 Thickeners and Stabilizers, 28 Granulation, 23 Disintegrants & Superdisintegrants, 19 Co-Processed Excipients, 17 Lubricants & Glidants, 17 Solubilizers, 14 Film Formers & Plasticizers, 12 Topical, 10 Chewable & Orodispersible Aids, 10 Taste Masking, 9 Empty Capsules, 8 Parenteral, 7 API Stability Enhancers, 5 Emulsifying Agents, 5 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

16 NEWS #PharmaBuzz

16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 53 Finished Drug Prices

MARKET PLACE

6 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

32 Health Canada Patents

32 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 3 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/11/2024	Aarti Pharmalabs	India	AARTI PHARMALABS LTD	19413	QUINAPRIL HYDROCHLORIDE USP	2006-05-08	Active	II	Complete	2021-01-07	2020-12-31
28/11/2024	Farmhispania	Spain	FARMHISPANIA SA	16735	QUINAPRIL HYDROCHLORIDE	2003-07-25	Active	II	N/A

Quinapril Hydrochloride

Quinapril hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers

11 USDMF

4 CEP/COS

5 EU WC

5 NDC API

6 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

5 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

205 FDF Dossiers

77 FDA Orange Book

90 Europe

4 Canada

8 Australia

26 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

9 SPI Pharma

2 Seqens

10 DKSH

1 Pharm-RX Chemical

5 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

11 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

4 ACG Worldwide

4 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

31 BASF

1 Clariant

10 Corel Pharma Chem

4 DFE Pharma

1 Finar

9 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

32 Kerry

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nomisma Healthcare

5 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

15 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

10 Sigachi Industries

2 The Dow Chemical Company

2 Ulanqab Kema New Material

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders

54 Coating Systems & Additives

40 Direct Compression

33 Controlled & Modified Release

28 Thickeners and Stabilizers

28 Granulation

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons